Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 1999

View Archived Issues

Scios signs drug screening and license agreement with Telik

Ares-Serono signs agreement with PowderJect for drug delivery system

Apotex extends agreement with Cangene

Preliminary results of testosterone replacement gel reported

Allelix clones GLP-2 receptor; advances development of ALX-0600

Preventive AIDS vaccine trial to begin in Thailand

Proteomics research grant awarded to Kinetek

New hemophilia treatment approved by Health Canada

Dainippon will initiate overseas trials of beta3 agonist

Yamanouchi, Ono establish codevelopment and marketing agreement for bisphosphonate

Zarix in-licenses oncology drug from Agouron

Another European market opens up to desirudin

Specific inhibitors of MEK for cancer and other proliferative disorders

New series of anticoagulants for oral administration developed at Lilly

More from SmithKline Beecham on p38 MAP kinase inhibitors

Patent covers new ADIR compounds with high affinity for imidazoline receptors

VUFB's phase III antirheumatic agent is available for licensing

Roche discloses inhibitors of TNF-alpha/TGF-alpha release, keratinocyte proliferation

First orally active, nonsteroidal androgen receptor agonist discovered at Ligand

CD-437, a novel retinoid compound targeted to the treatment of leukemia

Inhale branches out into pulmonary controlled release

AZT-cyclam/bicyclam prodrug conjugates designed at INSERM

Salix negotiates lafutidine license agreement with Fujirebio

FR-167653 compared to dexamethasone in acute lung inflammation

Wyeth-Ayerst seeks European approval of Rapamune

Amlodipine not associated with adverse arrhythmic events in CAD patients

CoCensys enters research agreements with Senju and Parke-Davis

Statins may be drugs of choice for adolescents with HeFH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...